Clinical burden of hemophilia in older adults: Beyond bleeding risk

Blood Rev. 2022 May:53:100912. doi: 10.1016/j.blre.2021.100912. Epub 2021 Dec 5.

Abstract

The prospect of hemophilia patients has dramatically improved in the last few decades with the introduction of various interventions that can effectively treat or prevent their bleeding risk. The life expectancy of patients can now reach that of the healthy population, but this has paved the way for several previously unrecognized morbidities to manifest in older adults with hemophilia. Such clinical complications are attributed to suboptimal management or poor access to effective therapy during childhood as well as chronicity and prolonged exposure to the underlying pathophysiology of the disease and its treatment. Complications common in the aging population are also becoming increasingly relevant in this vulnerable patient subgroup. In this review, we highlight peculiarities of such morbidities including chronic viral infections and liver disease, debilitating joint impairment and bone disease, cardiovascular and chronic kidney disease, and cancers. We also reflect on topics of special interest in adulthood such as sexuality.

Keywords: Aging; Complications; Hemophilia; Management; Morbidity.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Aging
  • Hemophilia A* / complications
  • Hemophilia A* / epidemiology
  • Hemophilia A* / therapy
  • Humans
  • Neoplasms* / complications